Eli Lilly | Créanciers Commerciaux



Trade Creditors Changement Date
AbbVie 2.94B 2.66B 2024-12
Abbott USD 4.21B 7.48B 2025-03
ALKERMES USD 59.84M 14.21M 2025-03
Amgen USD 2.41B 498M 2025-03
AstraZeneca 22.54B 79M 2025-03
Baxter International USD 968M 127M 2024-12
Biogen USD 391.5M 32.7M 2025-03
Bristol-Myers Squibb USD 4B 400M 2025-03
Drreddys Laboratories INR 36.02B 246M 2024-12
Eli Lilly USD 3.44B 213.4M 2025-03
Gilead Sciences USD 833M 70M 2024-12
GlaxoSmithKline 15.15B 186M 2025-03
Glaxosmithkline 3.46B 10.01B 2024-12
Indivior 183M 120M 2025-03
J&J USD 9.54B 766M 2025-03
Medtronic USD 2.29B 90M 2025-01
Merck USD 4.08B 493M 2024-12
Neurocrine Biosciences 110M 282.7M 2024-12
Novartis USD 4.57B 485M 2024-12
Novartis USD 4.57B 485M 2024-12
Novo Nordisk 24.08B 5.68B 2024-09
Perrigo USD 495.2M 36.7M 2024-12
Pfizer USD 5.63B 319M 2024-12
Prestige Brands USD 19.51M 11.67M 2024-12
Regeneron Pharmaceuticals USD 705.5M 4.18B 2025-03
Roche Holding 4.35B 828M 2024-12
Sanofi 21.62B 14.07B 2025-03
Sanofi 7.55B 118M 2024-12
United Therapeutics 6M 357.9M 2024-12
Zoetis USD 433M 29M 2024-12



Eli Lilly Créanciers Commerciaux - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.